FDA's Risk-Benefit Plan May Drive More Drug Approvals
The Food and Drug Administration's proposal for a new, more structured method for weighing the benefits and risks of a new drug could result in a more transparent and consistent approval...To view the full article, register now.
Already a subscriber? Click here to view full article